DRUG PRODUCT FORMULATIONS

Current TEMPOL Formulations

Matrix Biomed, Inc. has developed five (5) formulations with the active ingredient TEMPOL: MTS-01, MTS-02, MTS-10, MBM-01, and MBM-02. MTS-01 is a topical gel formulation of TEMPOL being developed for the prevention of hair loss (alopecia) induced by whole brain radiotherapy for the treatment of brain cancer and for radiation-induced skin damage secondary to radiation treatment of a variety of cancers. MTS-02 is a water-based gel formulation of TEMPOL being developed for the prevention of radiation-induced proctitis in patients with prostate cancer.  MTS-10 is a water-based mouthwash formulation of TEMPOL being developed for the prevention of oral mucositis caused by radiation therapy for the treatment of cancer. MBM-01 is a liquid formulation of TEMPOL being developed for the prevention of oral mucositis and other cisplatin and radiation induced toxicities where the patients ability to swallow has been compromised. MBM-02 is a gelatin capsule being developed for the prevention various chemotherapeutic induced toxicities in which the patient is able to swallow a gelatin capsule.

MTS-01

The MTS-01 drug product is a topical gel containing 70 mg/mL of TEMPOL (7% w/w) plus water, ethanol, and hydroxypropyl cellulose.  The composition of MTS-01 to be used for clinical trials for indications such as the prevention of radiation dermatitis.

MTS-02

The drug product MTS-02 contains 70 mg/mL TEMPOL (7% w/w) formulated as an aqueous gel with propylene glycol, methyl and propyl parabens, glycerin, buffers, and hydroxyethyl cellulose.  The product is packaged in a single use 60-mL syringe containing 50 grams of gel for rectal administration.

MBM-01

The drug product MBM-01 is a TEMPOL solution that is an orange-colored, aqueous solution containing 7% TEMPOL along with xanthan gum, xylitol, aspartame, acesulfame potassium, sodium saccharin, alcohol, peppermint and wintergreen oils.  The placebo contains the same excipients as the active product plus FD&C Yellow #6 for color matching. The composition of MBM-01 is currently the subject of our clinical trials preventing toxicities associated with chemotherapy and radiation.

MBM-02

The drug product MBM-02 is a TEMPOL Capsule, 200 mg.  The TEMPOL Capsules are a Swedish orange opaque, hard gelatin capsule, size 00 filled with 200 mg of TEMPOL drug product powder.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt